Acknowledgments
We thank Ms. Durga Devi T., laboratory technician and Ms. Kalaiselvi Rajendiran, PhD scholar, department of Biochemistry, JIPMER for help rendered in performing ELISA for the study parameters in our laboratory.
Conflict of interest statement
Authors’ conflict of interest disclosure: The authors stated that there are no conflicts of interest regarding the publication of this article.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
References
1. Chandran V, Raychaudhuri SP. Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis. J Autoimmunity 2010;34:314–21.10.1016/j.jaut.2009.12.001Search in Google Scholar PubMed
2. Campalani E, Barker JN. The clinical genetics of psoriasis. Current Genomics 2005;6:51–60.10.2174/1389202053202157Search in Google Scholar
3. Akay A, Pekcanlar A, Bozdag KE, Altintas L, Karaman A. Assessment of depression in subjects with psoriasis vulgaris and lichen planus. J Eur Acad Dermatol Venereol 2002;16:347–52.10.1046/j.1468-3083.2002.00467.xSearch in Google Scholar PubMed
4. Gupta MA, Gupta AK. Psychiatric and psychological co-morbidity in patients with dermatologic disorders: epidemiology and management. Am J Clin Dermatol 2003;4:833–42.10.2165/00128071-200304120-00003Search in Google Scholar PubMed
5. Gordon-Elliott JS, Muskin PR. Managing the patient with psychiatric issues in dermatologic practice. Clin Dermatol 2013;31:3–10.10.1016/j.clindermatol.2011.11.001Search in Google Scholar PubMed
6. De Berardis D, Campanella D, Gambi F, La Rovere R, Carano A, Conti CM, et al. The role of C-reactive protein in mood disorders. Int J Immunopathol Pharmacol 2006;19:721–5.10.1177/039463200601900402Search in Google Scholar PubMed
7. De Berardis D, Conti CM, Marini S, Ferri F, Iasevoli F, Valchera A, et al. Is there a role for agomelatine in the treatment of anxiety disorders? A review of published data. Int J Immunopathol Pharmacol 2013;26:299–304.10.1177/039463201302600203Search in Google Scholar PubMed
8. Vidrih B, Karlović D, Pasić MB, Uremović M, Mufić AK, Matosić A. A review of the psychoneuroimmunologic concepts on the etiology of depressive disorders. Acta Clin Croat 2012;51:403–9.Search in Google Scholar
9. Jaremka LM, Lindgren ME, Kiecolt-Glaser JK. Synergistic relationships among stress, depression, and troubled relationships: insights from psychoneuroimmunology. Depress Anxiety 2013;30:288–96.10.1002/da.22078Search in Google Scholar PubMed PubMed Central
10. Leonard BE. Impact of inflammation on neurotransmitter changes in major depression: an insight into the action of antidepressants. Prog Neuropsychopharmacol Biol Psychiatry 2014;48:261–7.10.1016/j.pnpbp.2013.10.018Search in Google Scholar PubMed
11. Brown RP, Kocsis JH, Caroff S, Amsterdam J, Winokur A, Stokes P, et al. Depressed mood and reality disturbance correlate with decrease nocturnal melatonin in depressed patients. Acta Psychiatr Scand 1987;76:272–5.10.1111/j.1600-0447.1987.tb02895.xSearch in Google Scholar PubMed
12. Grivas TB, Savvidou OD. Melatonin the “light of night” in human biology and adolescent idiopathic scoliosis. Scoliosis 2007;2:1–14.Search in Google Scholar
13. Esposito E, Cuzzocrea S. Anti-inflammatory activity of melatonin in central nervous system. Curr Neuropharmacol 2010;8:228–42.10.2174/157015910792246155Search in Google Scholar
14. Carrillo-Vico A, Lardone PJ, Alvarez-Sánchez N, Rodríguez-Rodríguez A, Guerrero JM. Melatonin: buffering the immune system. Int J Mol Sci 2013;14:8638–83.10.3390/ijms14048638Search in Google Scholar
15. Radogna F, Diederich M, Ghibelli L. Melatonin: a pleiotropic molecule regulating inflammation. Biochem Pharmacol 2010;80:1844–52.10.1016/j.bcp.2010.07.041Search in Google Scholar
16. Langley RG, Ellis CN. Evaluating psoriasis with psoriasis area and severity index, psoriasis global assessment, and lattice system physician’s global assessment. J Am Acad Dermatol 2004;51:563–9.10.1016/j.jaad.2004.04.012Search in Google Scholar
17. Beck AT, Steer RA. Manual for the beck depression inventory, 1993 ed. San Antonio, TX: The Psychological Corporation, 1987.10.1007/978-3-642-70486-4_13Search in Google Scholar
18. Beck AT, Steer RA, Ball R, Ranieri W. Comparison of beck depression inventories -IA and -II in psychiatric outpatient. J Pers Assess 1996;67:588–97.10.1207/s15327752jpa6703_13Search in Google Scholar
19. Mozzanica N, Tadini G, Radaelli A, Negri M, Pigatto P, Morelli M, et al. Plasma melatonin levels in psoriasis. Acta Derm Venereol 1988;68:312–6.Search in Google Scholar
20. Souetre E, Salvati E, Lacour JC, Belugou JL, Krebs B, Ortonne JP, et al. Psoralen and the suppression of melatonin secretion by bright light. Photochem Photobiol 1988;47:579–81.10.1111/j.1751-1097.1988.tb08847.xSearch in Google Scholar
21. Tooley GA, Armstrong SM, Norman TR, Sali A. Acute increases in night-time plasma melatonin levels following a period of meditation. Biol Psychol 2000;53:69–78.10.1016/S0301-0511(00)00035-1Search in Google Scholar
22. Srinivasan V, Pandi-Perumal SR, Trakht I, Spence DW, Hardeland R, Poeggeler B, et al. Pathophysiology of depression: role of sleep and the melatonergic system. Psychiatry Res 2009;165:201–14.10.1016/j.psychres.2007.11.020Search in Google Scholar PubMed
23. De Berardis D, Di Iorio G, Acciavatti T, Conti C, Serroni N, Olivieri L, et al. The emerging role of melatonin agonists in the treatment of major depression: focus on agomelatine. CNS Neurol Disord Drug Targets 2011;10:119–32.10.2174/187152711794488674Search in Google Scholar PubMed
24. Srinivasan V, De Berardis D, Shillcutt SD, Brzezinski A. Role of melatonin in mood disorders and the antidepressant effects of agomelatine. Expert Opin Investig Drugs 2012;21:1503–22.10.1517/13543784.2012.711314Search in Google Scholar PubMed
25. De Berardis D, Marini S, Fornaro M, Srinivasan V, Iasevoli F, Tomasetti C, et al. The melatonergic system in mood and anxiety disorders and the role of agomelatine: implications for clinical practice. Int J Mol Sci 2013;14:12458–83.10.3390/ijms140612458Search in Google Scholar PubMed PubMed Central
©2014 by Walter de Gruyter Berlin/Boston
